Imagine a world where most ovarian cancers could be prevented with a single, simple procedure. It sounds too good to be true, doesn’t it? But here’s the groundbreaking truth: surgeons are now advocating for a preventive surgery that could stop ovarian cancer before it even starts. This silent killer, notorious for its lack of early symptoms and reliable screening methods, claims over 12,000 lives annually in the U.S. alone. Yet, experts from the American College of Surgeons (ACS) believe a procedure called opportunistic salpingectomy—removing the fallopian tubes during other abdominal surgeries—could be a game-changer.
And this is the part most people miss: While ovarian cancer was once thought to originate in the ovaries, research now suggests that many aggressive forms actually begin in the fallopian tubes. These slender structures, crucial for fertilization but non-essential after a woman no longer desires children, are increasingly recognized as the starting point for this deadly disease. Despite this, many women are never informed about the option to remove them as a preventive measure.
At the ACS Clinical Congress 2025 in Chicago, Dr. Joseph V. Sakran of Johns Hopkins Medicine highlighted the urgency of integrating this procedure into general surgery practices. The panel emphasized the need to offer fallopian tube removal to post-reproductive women undergoing elective surgeries like hernia repair or gallbladder removal—after obtaining informed consent, of course. By incorporating this procedure into just 60% of eligible surgeries, experts estimate nearly 6,000 ovarian cancer deaths could be prevented annually. But here’s where it gets controversial: While the procedure is low-risk, it permanently eliminates the possibility of natural conception, though IVF remains an option. Should women be routinely counseled about this trade-off?
Emerging studies suggest that removing the fallopian tubes could prevent up to 80% of the most common and lethal ovarian cancers. For Dr. Kara Long of Memorial Sloan Kettering, this isn’t just a statistic—it’s about reducing pain, suffering, and loss. “We want patients to have a choice,” she says. Importantly, the procedure preserves the ovaries, which continue to produce essential hormones throughout a woman’s life.
The momentum behind this approach is growing. The American Cancer Society and the Break Through Cancer Foundation have joined forces to raise awareness among clinicians and the public. Even the American College of Obstetricians and Gynecologists acknowledges its potential. Yet, challenges remain. While the procedure adds just 5 to 13 minutes to existing surgeries, broader insurance coverage and more training for surgeons are needed. Here’s a thought-provoking question: Should opportunistic salpingectomy become a standard recommendation for women over 45 undergoing abdominal surgeries, or is it a decision best left to individual patient-doctor discussions?
Dr. Rebecca Stone of Johns Hopkins draws a parallel to preventive measures like colectomy for colon cancer, emphasizing that this could redefine the role of general surgeons in cancer prevention. “Expanding access to this procedure is one of the greatest challenges in medicine today,” she notes. But with rural areas often lacking surgical care, how can we ensure equitable access to this life-saving intervention?
What do you think? Is opportunistic salpingectomy a revolutionary step in cancer prevention, or does it raise ethical concerns about patient choice and fertility? Share your thoughts in the comments below. For journalists seeking more information, resources are available at www.facs.org/media-center/resources-for-journalists/, and experts can be reached at pressinquiry@facs.org.
About the American College of Surgeons: Founded in 1913, the ACS is the world’s largest surgical organization, dedicated to advancing surgical care and patient outcomes. With nearly 90,000 members, it continues to shape the future of surgery through education, advocacy, and innovation. Follow their work on social media to stay informed.
